Home › Funds › Cormorant Asset Management, LP › PRAX

Cormorant Asset Management, LP position in PRAX

PRAXIS PRECISION MEDICINES I · Health Care

Cormorant Asset Management, LP reported holding 640,000 shares of PRAX (PRAXIS PRECISION MEDICINES I) in its Q2 2026 13F filing — a position valued at US$214.3M, representing 10.98% of its reported portfolio and ranking #1 among its reported holdings. Cormorant Asset Management, LP has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)640.00K sh
Reported value held$214.27M
Portfolio Weight10.98%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's PRAX position evolved

Cormorant Asset Management, LP first disclosed a stake in PRAX in Q3 2023 at 9,500,000 shares (US$16.2M). The position peaked in Q1 2026 at 885,500 shares, worth US$285.3M. Across 12 filings, Cormorant Asset Management, LP increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 640,000 shares valued at US$214.3M — a reduction of -245,500 shares quarter over quarter.. Notable position changes include a 93% trim in Q4 2023 (shares rose 174% over the following quarter), a 107% increase in Q1 2024 (shares fell 32% over the following quarter), a 95% increase in Q4 2024 (shares fell 51% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.50M $16.25M New
Q4 2023 633.35K $14.11M Reduce
Q1 2024 1.31M $79.94M Add
Q2 2024 685.00K $28.33M Reduce
Q3 2024 870.00K $50.06M Add
Q4 2024 1.69M $130.31M Add
Q1 2025 1.75M $66.08M Add
Q2 2025 1.62M $68.33M Reduce
Q3 2025 1.00M $53.00M Reduce
Q4 2025 950.00K $280.00M Reduce
Q1 2026 885.50K $285.30M Reduce
Q2 2026 640.00K $214.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRAX and 13F data

PRAX (PRAXIS PRECISION MEDICINES I) is a Health Care company. 73 other funds we track also report a position in PRAX — the largest reported positions include Jupiter Topco LLC (US$1.15B), Janus Henderson Group (US$1.11B), PERCEPTIVE ADVISORS LLC (US$681.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRAX

All PRAX fund holders →

FAQ

How long has Cormorant Asset Management, LP held PRAX?

Cormorant Asset Management, LP has disclosed PRAX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Cormorant Asset Management, LP's current position in PRAX?

As of Q2 2026, Cormorant Asset Management, LP holds 640.00K shares of PRAX (PRAXIS PRECISION MEDICINES I), valued at $214.27M, representing 10.98% of its reported portfolio and ranking #1.

Has Cormorant Asset Management, LP been buying or selling PRAX?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in PRAX. The position peaked in Q1 2026 at 885.50K shares.

Which other funds hold PRAX?

Other major institutional holders of PRAX include Jupiter Topco LLC, Janus Henderson Group, PERCEPTIVE ADVISORS LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.